Tipifarnib in Head and Neck Squamous Cell Carcinoma With<i>HRAS</i>MutationsAlan L. Ho, Antonio Gualberto, Irene Braña et al.|Journal of Clinical Oncology|2021Cited by 196
Best Practice in Systemic Therapy for Head and Neck Squamous Cell CarcinomaSjoukje F. Oosting, Robert I. Haddad|Frontiers in Oncology|2019Cited by 77
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare CancersMarloes A.M. Peters, Sjoukje F. Oosting|Pathology & Oncology Research|2019Cited by 64
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaJ. Alberto Nakauma-González, Joost L. Boormans, Hans M. Westgeest et al.|European Urology|2022Cited by 46
Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinomaJ. Alberto Nakauma-González, Joost L. Boormans, Maud Rijnders et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4